Efficacy and safety of vaccination against pandemic 2009 influenza A (H1N1) virus among patients with rheumatic diseases. - Wikidata - awgldk - TriplyDB

Efficacy and safety of vaccination against pandemic 2009 influenza A (H1N1) virus among patients with rheumatic diseases.

Efficacy and safety of vaccination against pandemic 2009 influenza A (H1N1) virus among patients with rheumatic diseases.

http://www.wikidata.org/entity/Q30401020

about

Impact of anti-rheumatic treatment on immunogenicity of pandemic H1N1 influenza vaccine in patients with arthritis Safety and immunogenicity of co-administered MF59-adjuvanted 2009 pandemic and plain 2009-10 seasonal influenza vaccines in rheumatoid arthritis patients on biologicals.Is Systemic Lupus Erythematosus Associated With a Declined Immunogenicity and Poor Safety of Influenza Vaccination?: A Systematic Review and Meta-Analysis.TNF blockers show distinct patterns of immune response to the pandemic influenza A H1N1 vaccine in inflammatory arthritis patients.Abatacept and reduced immune response to pandemic 2009 influenza A/H1N1 vaccination in patients with rheumatoid arthritis.Aflunov®: a vaccine tailored for pre-pandemic and pandemic approaches against influenza.High disease activity: an independent factor for reduced immunogenicity of the pandemic influenza a vaccine in patients with juvenile systemic lupus erythematosus.2013 IDSA clinical practice guideline for vaccination of the immunocompromised host.Immunogenicity and Safety of Influenza Vaccination in Systemic Lupus Erythematosus Patients Compared with Healthy Controls: A Meta-Analysis.Is rheumatoid arthritis associated with reduced immunogenicity of the influenza vaccination? A systematic review and meta-analysis.Rituximab-treated patients have a poor response to influenza vaccination Immunogenicity of influenza H1N1 vaccination in mixed connective tissue disease: effect of disease and therapy.Immunization of patients with autoimmune inflammatory rheumatic diseases (the EULAR recommendations).Adjuvanted influenza vaccines.Effect of methotrexate, anti-tumor necrosis factor α, and rituximab on the immune response to influenza and pneumococcal vaccines in patients with rheumatoid arthritis: a systematic review and meta-analysis.Vaccines and biologics.Changing face of vaccination in immunocompromised hosts.Pediatric Rheumatology Association of Japan recommendation for vaccination in pediatric rheumatic diseases.Vaccination of patients with autoimmune inflammatory rheumatic diseases.Safety and immunogenicity of yellow fever 17D vaccine in adults receiving systemic corticosteroid therapy: an observational cohort study.Autoimmune response following influenza vaccination in patients with autoimmune inflammatory rheumatic disease.Impact of temporary methotrexate discontinuation for 2 weeks on immunogenicity of seasonal influenza vaccination in patients with rheumatoid arthritis: a randomised clinical trial.

P2860

Q30357450-778A7E2E-E15C-4538-B126-D5B4016B0615 Q30360610-73A02CAD-3BD3-4900-BA8B-825527EF5A63 Q30388063-D06374F5-B5E1-46F7-8452-A26967709497 Q30420493-41638D86-F2DD-48BE-86C8-EC96E0FE3E40 Q30420964-899B0E48-34F8-4895-97DD-ECE39ABA3B25 Q30424161-02847F0F-B6A4-450E-928F-C9FD04DC94DA Q30432642-8BE9747C-F149-4EB5-82A3-D9F0A8999A3E Q34390072-86CDE627-717F-4A55-9B18-1BDDC314E4AC Q35914564-A173ACA6-2110-4F4E-B035-BA3C7FF55090 Q36367842-BEE10F6B-56E1-4FFF-8FF7-CC40ED6182E3 Q36589247-CE9E060A-407D-4A27-81B0-77F5B14C68C3 Q36644797-61169FFF-F788-4C48-A935-0F5008DD4948 Q37974891-65C8F62D-9FBF-444B-921B-CA5BCEC332EA Q37976540-484D1C04-B0F1-47F9-BAE4-0B6F8B4B1C23 Q38171461-4CDA6BEE-BE8B-4568-BBEF-AE3214F15C69 Q38213192-CD364AE7-CBB6-43B3-9D6C-6B1986F5D00E Q38225998-F90801C6-6EC2-4400-BB5A-B6969F65B843 Q38266287-6FFE0D42-3561-49BF-9752-43C234E2716D Q38285275-7B5C4BEA-A9DA-43FC-B6F5-46E51E3B9474 Q40252321-1502856E-35D2-4FA6-AD87-89BB2AD50584 Q43172230-F2586D8E-80AB-4264-84D3-E44F84F66CB1 Q54249618-67647376-609E-45C6-A9E3-457C18B133C5

P2860

Efficacy and safety of vaccination against pandemic 2009 influenza A (H1N1) virus among patients with rheumatic diseases.

http://www.wikidata.org/entity/Q30401020

description

2011 nî lūn-bûn

@nan

2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Efficacy and safety of vaccina ...... ients with rheumatic diseases.

@ast

Efficacy and safety of vaccina ...... ients with rheumatic diseases.

@en

type

label

Efficacy and safety of vaccina ...... ients with rheumatic diseases.

@ast

Efficacy and safety of vaccina ...... ients with rheumatic diseases.

@en

prefLabel

Efficacy and safety of vaccina ...... ients with rheumatic diseases.

@ast

Efficacy and safety of vaccina ...... ients with rheumatic diseases.

@en

P1433

Q30401020-77FD78D5-6169-4FF9-BC13-B0AA5E3D9872

P1476

Q30401020-05FE512E-6DA4-4B42-9812-720A61AC65DD

P2093

Q30401020-34E3638E-031D-4D53-BBD5-B6AB61726B06

Q30401020-46F714F4-B1A9-4842-A302-F0F577790C42

Q30401020-5B9E54B1-0ED0-4126-91C9-785CBEB9EC3A

Q30401020-5CFED47B-1257-4FC6-8DAF-66DE7B3914D5

Q30401020-75A06B0E-1A0E-4F94-8361-224AC14BD14F

Q30401020-8BC7E867-9944-4727-8567-5556E3AD694C

Q30401020-9C6EBC51-E722-47B3-9DEA-CC9A6FC493F4

Q30401020-A7536190-2446-498F-AB59-2C641CBCFB5F

Q30401020-AC4772C7-8026-43D2-8D5A-6AE41AF43C34

Q30401020-DF6A67B0-E2B2-45F5-8BF1-E85B28B344F7

P2860

Q30401020-11F92185-A697-404B-A495-CBBB76DF82F9

Q30401020-12927392-1304-4B75-926B-EDAAF0D87182

Q30401020-13FEAD80-863E-4138-AAFD-36809F593277

Q30401020-1A9C6CE2-7522-451C-9AB7-DE2C626D5AE3

Q30401020-213C5853-4F1E-4A32-8B63-AC8C74896100

Q30401020-2AC13036-1920-4E27-B342-FABE9ABD8E08

Q30401020-568E7336-ABEC-4BAE-BD29-136A4403C76E

Q30401020-61D3A1F3-0E26-46BB-A806-75557BCFF9D9

Q30401020-6BC54E06-0377-4323-B67D-B828BF5BA96A

Q30401020-6C03650B-1CBC-4D77-A2F1-CBAB6B759EDF

P304

Q30401020-6F8DEA3F-48E9-4A0A-8C08-FB839CE634BC

P31

Q30401020-9ABF0D10-0557-4073-A24E-F53AFC674618

P356

Q30401020-7524F8A4-4F03-4C54-9B99-208F04D9A755

P433

Q30401020-53768492-5E18-485E-AE22-1FDBF38B60BF

P478

Q30401020-04F4A210-86B6-4A8C-A538-DB03D4A54AF6

P50

Q30401020-77519291-498C-4019-B3FA-DDB00D2D966E

Q30401020-97101967-8F44-4614-929B-6E24F6D0832D

P577

Q30401020-E12D3CAE-1A67-44A9-8302-A49203E8B393

P5875

Q30401020-8AB6D8F4-2ACB-43F2-98F1-B6E95D8F94FF

P698

Q30401020-50BEEF64-9D14-4E7B-8DCE-E017A7E46A30

P921

Q30401020-D1D993A6-D16C-4504-88E6-C7FA790AE0FC

P356

P1433

Arthritis Care and Research

P1476

Efficacy and safety of vaccina ...... ients with rheumatic diseases.

@en

P2093

Ayelet Brill

http://www.w3.org/2001/XMLSchema#string

Dan Caspi

http://www.w3.org/2001/XMLSchema#string

Daphna Paran

http://www.w3.org/2001/XMLSchema#string

David Levartovsky

http://www.w3.org/2001/XMLSchema#string

Irena Wigler

http://www.w3.org/2001/XMLSchema#string

Jonathan Wollman

http://www.w3.org/2001/XMLSchema#string

Michal Mandelboim

http://www.w3.org/2001/XMLSchema#string

Mitchell Schwaber

http://www.w3.org/2001/XMLSchema#string

Ori Elkayam

http://www.w3.org/2001/XMLSchema#string

Sharon Amir

http://www.w3.org/2001/XMLSchema#string

P2860

The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis

Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus

The first pandemic of the 21st century: a review of the 2009 pandemic variant influenza A (H1N1) virus.

Vaccination, squalene and anti-squalene antibodies: facts or fiction?

High mortality from respiratory failure secondary to swine-origin influenza A (H1N1) in South Africa.

Safety and immunogenicity of influenza A H1N1 vaccines.

Clinical features of H1N1 2009 infection in critically ill immunocompromised patients.

Low rate of seroconversion after vaccination with a split virion, adjuvanted pandemic H1N1 influenza vaccine in HIV-1-infected patients.

Outcomes from pandemic influenza A H1N1 infection in recipients of solid-organ transplants: a multicentre cohort study

Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials.

P304

1062-1067

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/ACR.20465

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

63

http://www.w3.org/2001/XMLSchema#string

P50

P577

2011-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

50598625

http://www.w3.org/2001/XMLSchema#string

P698

21425247

http://www.w3.org/2001/XMLSchema#string

P921